This is in line with the study of Tan and colleagues which demonstrates that ERBB2 binds to and colocalizes with cyclin B-CDK1 complexes and phosphorylates Tyr15 of CDK1 in breast cancer cells [12]. Here, CDK1 is linked to breast carcinoma.